KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Edwards Lifesciences (EW) Non-Current Receivables (2016)

Edwards Lifesciences has reported Non-Current Receivables over the past 6 years, most recently at $5.3 million for Q3 2016.

  • Quarterly results put Non-Current Receivables at $5.3 million for Q3 2016, down 3.64% from a year ago — trailing twelve months through Sep 2016 was $5.3 million (down 3.64% YoY), and the annual figure for FY2015 was $3.6 million, down 37.93%.
  • Non-Current Receivables for Q3 2016 was $5.3 million at Edwards Lifesciences, roughly flat from $5.3 million in the prior quarter.
  • Over the last five years, Non-Current Receivables for EW hit a ceiling of $21.4 million in Q1 2012 and a floor of $3.6 million in Q4 2015.
  • Median Non-Current Receivables over the past 5 years was $7.3 million (2013), compared with a mean of $8.4 million.
  • Biggest five-year swings in Non-Current Receivables: crashed 59.76% in 2012 and later grew 19.27% in 2013.
  • Edwards Lifesciences' Non-Current Receivables stood at $9.9 million in 2012, then decreased by 26.26% to $7.3 million in 2013, then decreased by 20.55% to $5.8 million in 2014, then crashed by 37.93% to $3.6 million in 2015, then skyrocketed by 47.22% to $5.3 million in 2016.
  • The last three reported values for Non-Current Receivables were $5.3 million (Q3 2016), $5.3 million (Q2 2016), and $5.8 million (Q1 2016) per Business Quant data.